259 related articles for article (PubMed ID: 9876554)
1. Assessment of pharmaceutical quality of furosemide tablets from multinational markets.
Qureshi SA; McGilveray IJ
Drug Dev Ind Pharm; 1998 Nov; 24(11):995-1005. PubMed ID: 9876554
[TBL] [Abstract][Full Text] [Related]
2. Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study.
McNamara PJ; Foster TS; Digenis GA; Patel RB; Craig WA; Welling PG; Rapaka RS; Prasad VK; Shah VP
Pharm Res; 1987 Apr; 4(2):150-3. PubMed ID: 3509139
[TBL] [Abstract][Full Text] [Related]
3. In vitro Comparative Quality Assessment of Different Brands of Furosemide Tablets Marketed in Northwest Ethiopia.
Abebe S; Ketema G; Kassahun H
Drug Des Devel Ther; 2020; 14():5119-5128. PubMed ID: 33262573
[TBL] [Abstract][Full Text] [Related]
4. A bioequivalence study of two products of furosemide tablets.
Awad R; Arafat T; Saket M; Saleh M; Gharaibeh M; Zmeili S; Sallam E; Shubair M; Qobrosi S
Int J Clin Pharmacol Ther Toxicol; 1992 Jan; 30(1):18-23. PubMed ID: 1551740
[TBL] [Abstract][Full Text] [Related]
5. Prolonged-release hydroxypropyl methylcellulose matrix tablets of furosemide for administration to dogs.
Smal J; Marvola M; Liljequist C; Happonen I
J Vet Pharmacol Ther; 1996 Dec; 19(6):482-7. PubMed ID: 8971678
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Discrepancy between the European Pharmacopoeia Test and an Adopted United States Pharmacopoeia Test Regarding the Weight Uniformity of Scored Tablet Halves: Is Harmonization Required?
Zaid AN; Ghoush AA; Al-Ramahi R; Are'r M
PDA J Pharm Sci Technol; 2012; 66(1):20-7. PubMed ID: 22307659
[TBL] [Abstract][Full Text] [Related]
7. Enzyme content and acid stability of enteric-coated pancreatic enzyme products in vitro.
Case CL; Henniges F; Barkin JS
Pancreas; 2005 Mar; 30(2):180-3. PubMed ID: 15714141
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence evaluation of two brands of furosemide 40 mg tablets (Salurin and Lasix) in healthy human volunteers.
Najib N; Idkaidek N; Beshtawi M; Bader M; Admour I; Alam SM; Zaman Q; Dham R
Biopharm Drug Dispos; 2003 Sep; 24(6):245-9. PubMed ID: 12973821
[TBL] [Abstract][Full Text] [Related]
9. In vitro quality evaluation of leading brands of ciprofloxacin tablets available in Bangladesh.
Uddin MS; Mamun AA; Hossain MS; Asaduzzaman M; Sarwar MS; Rashid M; Herrera-Calderon O
BMC Res Notes; 2017 May; 10(1):185. PubMed ID: 28558832
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the quality of four Mexican drug products containing sodium naproxen.
Hernández-Abad VJ; Castañeda-Hernández G; García-Jiménez S; Marroquín-Segura R; Sánchez-González E
J Clin Pharm Ther; 2008 Jun; 33(3):237-42. PubMed ID: 18452410
[TBL] [Abstract][Full Text] [Related]
11. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of USP apparatus 3 for dissolution testing of immediate-release products.
Yu LX; Wang JT; Hussain AS
AAPS PharmSci; 2002; 4(1):E1. PubMed ID: 12049485
[TBL] [Abstract][Full Text] [Related]
13. Variable furosemide absorption and poor predictability of response in elderly patients.
Murray MD; Haag KM; Black PK; Hall SD; Brater DC
Pharmacotherapy; 1997; 17(1):98-106. PubMed ID: 9017769
[TBL] [Abstract][Full Text] [Related]
14. Comparison of simvastatin tablets from the US and international markets obtained via the Internet.
Veronin MA; Nguyen NT
Ann Pharmacother; 2008 May; 42(5):613-20. PubMed ID: 18413690
[TBL] [Abstract][Full Text] [Related]
15. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.
Qureshi SA; McGilveray IJ
Eur J Pharm Sci; 1999 Feb; 7(3):249-58. PubMed ID: 9845813
[TBL] [Abstract][Full Text] [Related]
16.
Medina-López R; Guillén-Moedano S; Hurtado M
ADMET DMPK; 2020; 8(4):411-423. PubMed ID: 35300193
[TBL] [Abstract][Full Text] [Related]
17. Comparative bioavailability of furosemide from solution and 40 mg tablets with different dissolution characteristics following oral administration in normal men.
Waller ES; Crismon ML; Smith RV; Bauza MT; Doluisio JT
Biopharm Drug Dispos; 1988; 9(2):211-8. PubMed ID: 3370308
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and pharmacokinetics of furosemide marketed in Thailand.
Kaojarern S; Poobrasert O; Utiswannakul A; Kositchaiwat U
J Med Assoc Thai; 1990 Apr; 73(4):191-7. PubMed ID: 2394955
[TBL] [Abstract][Full Text] [Related]
19. Lot-to-lot variation in dissolution of tolbutamide tablets.
Ayres JW
Am J Hosp Pharm; 1980 Oct; 37(10):1329-32. PubMed ID: 7424928
[TBL] [Abstract][Full Text] [Related]
20. Cause of high variability in drug dissolution testing and its impact on setting tolerances.
Qureshi SA; Shabnam J
Eur J Pharm Sci; 2001 Jan; 12(3):271-6. PubMed ID: 11113646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
